[go: up one dir, main page]

GB202502170D0 - Antisense oligonucleotides for the treatment of disease - Google Patents

Antisense oligonucleotides for the treatment of disease

Info

Publication number
GB202502170D0
GB202502170D0 GBGB2502170.0A GB202502170A GB202502170D0 GB 202502170 D0 GB202502170 D0 GB 202502170D0 GB 202502170 A GB202502170 A GB 202502170A GB 202502170 D0 GB202502170 D0 GB 202502170D0
Authority
GB
United Kingdom
Prior art keywords
disease
treatment
antisense oligonucleotides
antisense
oligonucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB2502170.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ProQR Therapeutics II BV
Original Assignee
ProQR Therapeutics II BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ProQR Therapeutics II BV filed Critical ProQR Therapeutics II BV
Priority to GBGB2502170.0A priority Critical patent/GB202502170D0/en
Publication of GB202502170D0 publication Critical patent/GB202502170D0/en
Pending legal-status Critical Current

Links

GBGB2502170.0A 2025-02-13 2025-02-13 Antisense oligonucleotides for the treatment of disease Pending GB202502170D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2502170.0A GB202502170D0 (en) 2025-02-13 2025-02-13 Antisense oligonucleotides for the treatment of disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2502170.0A GB202502170D0 (en) 2025-02-13 2025-02-13 Antisense oligonucleotides for the treatment of disease

Publications (1)

Publication Number Publication Date
GB202502170D0 true GB202502170D0 (en) 2025-04-02

Family

ID=95563213

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2502170.0A Pending GB202502170D0 (en) 2025-02-13 2025-02-13 Antisense oligonucleotides for the treatment of disease

Country Status (1)

Country Link
GB (1) GB202502170D0 (en)

Similar Documents

Publication Publication Date Title
AU2023390632A1 (en) Antisense oligonucleotides for the treatment of cardiovascular disease
GB202502170D0 (en) Antisense oligonucleotides for the treatment of disease
AU2024246572A1 (en) Antisense oligonucleotides for the treatment of liver disease
GB202405143D0 (en) Antisense oligonucleotides for the treatment of poly-q disease
GB202502333D0 (en) Antisense oligonucleotides for the treatment of liver disease
GB202414347D0 (en) Antisense oligonucleotides for the treatment of liver disease
GB202410081D0 (en) Antisense oligonucleotides for the treatment of cardiovascular disease
GB202306756D0 (en) Antisense oligonucleotides for the treatment of cardiovascular disease
GB202218585D0 (en) Antisense oligonucleotides for the treatment of cardiovascular disease
GB202400404D0 (en) Antisense oligonucleotides for the treatment of polg-related disorders
GB202316851D0 (en) Antisense oligonucleotides for the treatment of moyamoya disease
IL319679A (en) Antisense oligonucleotides for the treatment of canavan disease
GB202318087D0 (en) Antisense oligonucleotides for the treatment of liver disease
GB202304438D0 (en) Antisense oligonucleotides for the treatment of liver disease
GB202502460D0 (en) Antisense oligonucleotides for the treatment of cancer
GB202418430D0 (en) Antisense oligonucleotides for the treatment of migrane
GB202418144D0 (en) Antisense oligonucleotides for the treatment of parkinson's disease
GB202508058D0 (en) Antisense oligonucleotides for the treatment of renal disorders
GB202502057D0 (en) Antisense oligonucleotides for the treatment of renal disorders
GB202404654D0 (en) Antisense oligonucleotides for the treatment of huntington's disease
GB202418028D0 (en) Antisense oligonucleotides for the treatment of fatty liver disease
GB202405813D0 (en) Antisense oligonucleotides for the treatment of fatty liver disease
GB202410297D0 (en) Antisense oligonucleotides for the treatment of Wilson's disease
GB202417415D0 (en) Antisense oligonucleotides for the treatment of metabolic disorders
GB202410747D0 (en) Antisense oligonucleotides for the treatment of metabolic disorders